Over-the-counter analgesics and risk of ovarian cancer

Lancet

Volumn 351, Issue 9096, 1998, Pages 104-107

  Cramer, Daniel W ^a,c   Harlow, Bernard L ^a   Titus Ernstoff, Linda ^b   Bohlke, Kari ^a   Welch, William R ^a   Greenberg, E Robert ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; IBUPROFEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL;

ADULT; AGE; AGED; ARTHRITIS; ARTICLE; CANCER RISK; CONTROLLED STUDY; DRUG USE; EDUCATION; FEMALE; HEADACHE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OVARY CANCER; PARITY; PRIORITY JOURNAL; RELIGION; UNITED STATES;

EID: 0032501741     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)08064-1     Document Type: Article

References (15)

1. 1 Berkel HJ, Holcombe RF, Middlebrooks M, Kannan K. Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev 1996; 18: 205-17.
2. 2 Greenberg ER, Baron JA. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents. In: Stewart BW, McGregor O, Klelhues P, eds. Principles of chemoprevention. IARC Scientific Publications no 139. Lyon: International Agency for Research on Cancer, 1996: 91-98.
3. 3 Goodwin JS. Prostaglandins and host defense in cancer. Med Clin North Am 1981; 65: 829-44.
4. 4 Marnett LJ. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med 1995; 24: 103-06.
5. 5 Shiff SJ, Koutsos MI, Qiao L, et al. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 1996; 222: 179-88.
6. 6 Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138-46.
7. 7 Muscat JE, Stellman SD, Wynder EL. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 1994; 74: 1847-54.
8. 8 Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593-96.
9. 9 Logan RF, Little J, Hawtin PG, et al. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993; 309: 285-89.
10. 10 Peleg II, Maibach HT, Brown SH, et al. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994; 154: 394-99.
11. 11 International Agency for Research on Cancer, World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans. Pharmaceutical Drugs, 17-24 October 1989. IARC monographs, Vol 50; Lyon, 1990.
12. 12 Isenhower WD Jr, Newbold RR, Cefalo RC, Korach KS, McLachlan JA. Absence of estrogenic activity in some drugs commonly used during pregnancy. Biol Res Preg Perinatol 1986; 7: 6-10.
13. 13 National Toxicology Program. Toxicology and carcinogenesis studies of acetaminophen (CAS No 103-9-2) in F344/N rats and B6C3F1 mice (feed studies). Technical report series no 394. NIH publication no 93-2849, Research Triangle Park, North Carolina, USA, 1993.
14. 14 Pasha KV, Vijayan E. Glutathione distribution in rat brain at different ages and the effect of intraventricular glutathione on gonadotropin levels in overariectomized steroid-primed rats. Brain Res Bull 1989; 22: 617-19.
15. 15 Santa-Coloma TA, Grasso P, Reichert LE. Sulfhydryl groups are involved in the interaction of FSH with its receptor. Biochem Biophys Res Commun 1991; 176: 1256-61.